SCHEMBL4975434

SCHEMBL4975434

CCCCOC(=O)N1CCC(Oc2ccc([N+](=O)[O-])cc2OC)CC1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 5/20 0.52
PDE4A P27815 3/20 0.52
PDE4C Q08493 3/20 0.52
PDE4D Q08499 3/20 0.52
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
NPC1 O15118 1/20 0.46
MTOR P42345 1/20 0.46
RAB9A P51151 1/20 0.46
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
ALDH1A1 P00352 2/20 0.43
HRH2 P25021 1/20 0.43
HRH1 P35367 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3975186 0.88 ALDH1A1 (0.45) PDE4BPDE4APDE4CPDE4DKMT2A
SCHEMBL23466891 0.82 PDE4B (0.45) PDE4BPDE4APDE4CPDE4DCHRM2
SCHEMBL2812864 0.82 NPSR1 (0.50) PDE4BPDE4APDE4CPDE4DKMT2A
SCHEMBL30996468 0.82 SLC6A2 (0.47) KMT2AMEN1ALDH1A1HRH2HRH1
SCHEMBL30996465 0.82 SLC6A2 (0.47) KMT2AMEN1ALDH1A1HRH2HRH1
SCHEMBL2814379 0.82 PDE4B (0.63) PDE4BPDE4APDE4CPDE4DALDH1A1
SCHEMBL13210805 0.82 PDE4B (0.54) PDE4BPDE4APDE4CPDE4DKMT2A
SCHEMBL19901712 0.79 PDE4B (0.52) PDE4BPDE4APDE4CPDE4DKMT2A
SCHEMBL15531867 0.79 HRH2 (0.48) KMT2AMEN1ALDH1A1HRH2HRH1
SCHEMBL15514870 0.78 NPSR1 (0.48) KMT2AMEN1ALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984350-A1 PYRIMIDINE DERIVATIVES USED AS PI-3 KINASE INHIBITORS Novartis AG (CH) 2008-10-29 EP disclosed
WO-2007084786-A1 PYRIMIDINE DERIVATIVES USED AS PI-3 KINASE INHIBITORS NOVARTIS AG (CH) 2007-07-26 WO disclosed